In brief
- Three cancers of the upper and lower urinary tract: renal cell carcinoma (from the tubular epithelium of the kidney), upper tract urothelial carcinoma (renal pelvis and ureter) and bladder cancer; a cystectomy then needs a urinary diversion.
- Key to diagnosis: visible haematuria in an adult is cancer until proven otherwise; a renal mass is staged with contrast CT, a bladder tumour with cystoscopy and TURBT (transurethral resection of bladder tumour) that includes detrusor muscle.
- Key to treatment: partial nephrectomy for T1 renal tumours; nephroureterectomy for high-risk upper tract tumours; TURBT plus intravesical therapy for non-muscle-invasive bladder cancer; neoadjuvant cisplatin then radical cystectomy for muscle-invasive disease.
Renal cell carcinoma (RCC)
Definition and epidemiology
RCC is a malignant tumour of the renal parenchyma arising from tubular epithelium; it makes up about 2% of adult cancers.
- Men are affected about 1.5 times as often as women; peak age is 60–70 years.
Risk factors
- Acquired: smoking, obesity, hypertension, long-term dialysis (acquired cystic kidney disease).
- Hereditary (about 2–4%): von Hippel–Lindau disease (VHL gene, chromosome 3p; clear cell RCC), hereditary papillary RCC (MET), Birt–Hogg–Dubé syndrome, tuberous sclerosis, fumarate hydratase (FH) deficiency. Suspect a syndrome with young age, bilateral or multifocal tumours.
Classification (WHO 2022, 5th edition)
Grading is by the WHO/ISUP system, grades 1–4 (the Fuhrman grade is obsolete). Sarcomatoid change in any subtype means aggressive disease.
Clinical features
- More than half are now found incidentally on imaging.
- The classic triad of flank pain, haematuria and a palpable mass is present in under 10% and means advanced disease.
- A left varicocele that does not empty when lying (tumour thrombus blocking the left renal vein) and leg oedema (caval involvement).
- Paraneoplastic syndromes (about 30%): hypertension (renin), polycythaemia (erythropoietin), hypercalcaemia (PTH-related peptide), Stauffer syndrome (non-metastatic liver dysfunction), fever, anaemia, weight loss, raised ESR.
- Metastases: lung (commonest), bone (lytic), liver, brain, adrenal.
Diagnosis
- Ultrasound often finds the mass; contrast-enhanced CT characterises it: solid tissue that enhances by about 15–20 Hounsfield units or more is suspicious. MRI when contrast is contraindicated and to define venous thrombus.
- Staging adds chest CT. Blood tests: creatinine/eGFR, calcium, haemoglobin, LDH, liver enzymes.
- Biopsy is not routine before nephrectomy; it is used before ablation, active surveillance or systemic therapy.
Contrast CT: a large rounded mass in the left kidney enhances less than normal parenchyma (left to right: corticomedullary phase axial, coronal, parenchymal phase).